KR100542875B1 - 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법 - Google Patents
상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법 Download PDFInfo
- Publication number
- KR100542875B1 KR100542875B1 KR1020030020422A KR20030020422A KR100542875B1 KR 100542875 B1 KR100542875 B1 KR 100542875B1 KR 1020030020422 A KR1020030020422 A KR 1020030020422A KR 20030020422 A KR20030020422 A KR 20030020422A KR 100542875 B1 KR100542875 B1 KR 100542875B1
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogel
- dressing
- carrageenan
- concentration
- weight
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 149
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000000679 carrageenan Substances 0.000 claims abstract description 68
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 68
- 229920001525 carrageenan Polymers 0.000 claims abstract description 68
- 229940113118 carrageenan Drugs 0.000 claims abstract description 68
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 68
- 239000000499 gel Substances 0.000 claims abstract description 54
- 239000000203 mixture Substances 0.000 claims abstract description 48
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 45
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 45
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 27
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 20
- 230000005855 radiation Effects 0.000 claims abstract description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 55
- 229920001223 polyethylene glycol Polymers 0.000 claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 17
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 8
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 230000036560 skin regeneration Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 229920001451 polypropylene glycol Polymers 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229940051250 hexylene glycol Drugs 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 229940093476 ethylene glycol Drugs 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 238000010894 electron beam technology Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 3
- 229920000249 biocompatible polymer Polymers 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 60
- 206010052428 Wound Diseases 0.000 description 29
- 208000027418 Wounds and injury Diseases 0.000 description 29
- 238000001879 gelation Methods 0.000 description 23
- 230000008961 swelling Effects 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- 239000003795 chemical substances by application Substances 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 108010076876 Keratins Proteins 0.000 description 8
- 102000011782 Keratins Human genes 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 8
- 239000011148 porous material Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 235000010419 agar Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000003796 beauty Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000004299 exfoliation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003999 initiator Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A61F13/01025—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6955—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a plaster, a bandage, a dressing or a patch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/18—Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment
Abstract
Description
겔화율(%) | 팽윤도(%) | 겔강도(kgf·cm2) | |
에틸렌글리콜 | 46 | 7,800 | 0.41 |
프로필렌글리콜 | 43 | 8,500 | 0.31 |
1,3-부틸렌글리콜 | 39 | 9,100 | 0.27 |
헥실렌글리콜 | 34 | 13,000 | 0.20 |
글리세린 | 48 | 7,000 | 0.42 |
폴리프로필렌글리콜 | 50 | 6,600 | 0.45 |
솔비톨 | 27 | 21,000 | 0.14 |
만니톨 | 30 | 17,000 | 0.15 |
시간 | 수분 공급 정도 (%) |
5분 | 3.91 |
10분 | 4.45 |
20분 | 6.53 |
30분 | 8.40 |
1시간 | 12.20 |
2시간 | 23.58 |
3시간 | 31.48 |
5시간 | 53.07 |
7시간 | 64.56 |
9시간 | 70.91 |
12시간 | 78.80 |
Claims (10)
- 폴리비닐피롤리돈, 다가알콜 및 카라기난으로 이루어진 조성물 5~40중량% 및 물 잔부를 포함하는 수화겔 드레싱.
- 제 1항에 있어서, 상기 조성물은 다가알콜 1∼10 중량%, 카라기난 0.1∼10 중량% 및 잔부가 폴리비닐피롤리돈인 것을 특징으로 하는 수화겔 드레싱.
- 제 1항에 있어서, 상기 폴리비닐피롤리돈의 수평균분자량이 200,000∼1,300,000 달톤인 것을 특징으로 하는 수화겔 드레싱.
- 제 1항에 있어서, 상기 다가알콜이 에틸렌글리콜, 프로필렌글리콜, 1,3-부틸렌글리콜, 헥실렌글리콜, 글리세린, 폴리에틸렌글리콜, 폴리프로필렌글리콜, 솔비톨, 만니톨 중에서 하나 또는 2개 이상 혼합하여 사용하는 것을 특징으로 하는 수화겔 드레싱
- 제 4항에 있어서, 상기 폴리에틸렌 글리콜의 수평균 분자량이 200∼600 달톤이고, 폴리프로필렌글리콜의 수평균 분자량이 200∼450 달톤인 것을 특징으로 하는 수화겔 드레싱.
- 폴리비닐피롤리돈, 다가알콜 및 카라기난을 혼합하여 5~40 중량%의 수용액을 제조하는 단계 (단계 1);상기 수용액을 트레이에 부어 겔 상태 시트 형태로 성형하는 단계 (단계 2);상기 시트를 포장하는 단계 (단계 3); 및상기 포장된 시트에 방사선을 조사하는 단계 (단계 4)로 이루어진 수화겔 드레싱의 제조방법.
- 삭제
- 제 6항에 있어서, 상기 방사선이 감마선(γ-rays) 또는 전자선(β-rays)이며, 조사량이 10∼100 kGy인 것을 특징으로 하는 제조방법.
- 제 1항의 수화겔 드레싱을 이용하여 피부 재생 치료에 적용하는 상처치료용 드레싱.
- 제 1항의 수화겔 드레싱을 이용하여 피부 미용에 적용하는 피부미용 팩제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030020422A KR100542875B1 (ko) | 2003-04-01 | 2003-04-01 | 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030020422A KR100542875B1 (ko) | 2003-04-01 | 2003-04-01 | 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040085646A KR20040085646A (ko) | 2004-10-08 |
KR100542875B1 true KR100542875B1 (ko) | 2006-01-20 |
Family
ID=37368608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030020422A KR100542875B1 (ko) | 2003-04-01 | 2003-04-01 | 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100542875B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100740596B1 (ko) | 2005-02-28 | 2007-07-18 | 이정욱 | 점착밴드형 수화겔 드레싱 및 그 제조방법 |
KR102211502B1 (ko) * | 2019-08-12 | 2021-02-03 | 최영준 | 원적외선 원료를 활용한 피부접착용 패치 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100612374B1 (ko) * | 2004-08-16 | 2006-08-16 | 한국원자력연구소 | 수분 방출 방지층을 함유한 상처 치료용 수화겔 및 그제조 방법 |
KR100772494B1 (ko) * | 2006-08-09 | 2007-11-01 | 한국원자력연구원 | 방사선 조사에 의한 아토피 피부염 치료용 수화겔 |
EP1889608B1 (en) | 2006-08-09 | 2012-11-28 | Korea Atomic Energy Research Institute | Therapeutic hydrogel for atopic dermatitis and preparation method thereof |
KR101139434B1 (ko) * | 2009-11-24 | 2012-04-27 | 주식회사 리온 | 돼지피부를 이용한 드레싱재의 제조방법 |
KR101507301B1 (ko) * | 2011-10-28 | 2015-04-01 | 주식회사 제닉 | 점착성 하이드로겔 조성물 및 이를 이용한 점착성 하이드로겔 시트의 제조방법 |
KR101607849B1 (ko) * | 2015-11-10 | 2016-03-31 | 영남대학교 산학협력단 | 생분해성 고분자 필름 및 그 제조방법 |
KR20190098881A (ko) | 2018-02-14 | 2019-08-23 | 조석형 | 폴리우레탄 폼과 하이드로화이버가 복합화돤 쉬트의 제조방법, 이로부터 제조된 창상 피복제 |
KR102138060B1 (ko) * | 2018-08-13 | 2020-07-28 | 한국원자력연구원 | 마이크로니들형 하이드로겔 제조용 조성물 및 마이크로니들형 하이드로겔의 제조방법 |
KR20210000009A (ko) | 2019-06-24 | 2021-01-04 | 조석형 | 항균성과 가교특성을 동시에 부여하는 수용성 하이드로화이버 부직포 제조방법, 이로부터 제조된 수용성 하이드로화이버 부직포를 이용한 운드드레싱 |
KR102393902B1 (ko) * | 2019-12-24 | 2022-05-04 | 한국원자력연구원 | 전도성 마이크로니들 패치용 조성물, 전도성 마이크로니들 패치 및 이의 제조방법 |
KR102553868B1 (ko) * | 2021-05-03 | 2023-07-07 | 수바이오 주식회사 | 점착성 투명 다기능 창상피복재의 제조방법 |
-
2003
- 2003-04-01 KR KR1020030020422A patent/KR100542875B1/ko active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100740596B1 (ko) | 2005-02-28 | 2007-07-18 | 이정욱 | 점착밴드형 수화겔 드레싱 및 그 제조방법 |
KR102211502B1 (ko) * | 2019-08-12 | 2021-02-03 | 최영준 | 원적외선 원료를 활용한 피부접착용 패치 |
Also Published As
Publication number | Publication date |
---|---|
KR20040085646A (ko) | 2004-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2617260B2 (ja) | 創傷治療用ゲル配合物 | |
KR100349020B1 (ko) | 폴리비닐피롤리돈과키토산유도체의상호반응에의해형성된겔 | |
US6635272B2 (en) | Wound dressing and drug delivery system | |
US5204110A (en) | High absorbency hydrogel wound dressing | |
RU2273471C2 (ru) | Гели, образованные при взаимодействии поливинилпирролидона с производными хитозана | |
EP0532275B1 (en) | Web dressing and method for its production | |
KR100542875B1 (ko) | 상처치료용 드레싱 또는 팩제로 이용할 수 있는 수화겔드레싱 및 그의 제조방법 | |
KR101582660B1 (ko) | 방사선을 이용한 콜라겐 함유 하이드로겔 마스크 팩 제조 | |
KR101985368B1 (ko) | 보습력이 우수한 하이드로겔 조성물 및 이를 이용한 시트 | |
JP2007512410A (ja) | 皮膚接着性ヒドロゲル | |
WO2003092756A1 (en) | Multi-layer synthetic dressing with cooling characteristics | |
Bielecki et al. | Wound dressings and cosmetic materials from bacterial nanocellulose | |
US20050251082A1 (en) | Removable cavity wound dressings | |
CA2470639C (en) | Preparation for wound healing and prevention of bandage adhesion to the wound | |
JP2005095331A (ja) | 魚皮真皮コラーゲンを含有する発泡体シートおよびその用途 | |
KR100740596B1 (ko) | 점착밴드형 수화겔 드레싱 및 그 제조방법 | |
KR100459494B1 (ko) | 상처 치료용 수화겔의 제조방법 | |
JPH04371161A (ja) | キチン又はキトサンの綿状物 | |
KR102312313B1 (ko) | 수용성난각막단백질 및 수용성고분자키토산을 포함하는 피부재생용 기능성 실리카하이드로겔 마스크팩, 및 이의 제조방법 | |
WO2021186188A1 (en) | Debridement composition | |
RU70792U1 (ru) | Медицинский аппликатор | |
Wang et al. | Temporary Skin Substitute from Non-Antigenic Dextran Hydrogel | |
Ghanim et al. | Insight into Topical Preparations for Wound Healing: Traditional and Modern Dressings | |
JPS6048181B2 (ja) | 創傷カバ−剤 | |
TW202241377A (zh) | 一種用於刺青護色之濕式敷料及其使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130102 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20131227 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20141230 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160105 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20171207 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190102 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20200102 Year of fee payment: 15 |